Endocrine Society Shares Information about Endocrine Research with Congressional Offices

The Endocrine Society has launched a series of educational briefings for congressional offices about endocrine research.


On March 30, we hosted a virtual congressional briefing on COVID-19 and diabetes. Our panel included Congresswoman Kim Schrier (WA-08), the only U.S. Representative living with type 1 diabetes and a pediatrician; director of the National Institutes of Diabetes, Digestive and Kidney Diseases (NIDDK) Griffin P. Rodgers, MD, director of the NIDDK Division of Endocrinology and Metabolism, William Cefalu, MD; and Endocrine Society members Joshua Joseph, MD, MPH, FAHA, and Mary Korytkowski, MD.


Congressional staff learned about how people with diabetes have more severe cases and poorer outcomes from COVID-19; the need to address racial and ethnic disparities in diabetes and COVID-19; what we now know about COVID-19 and diabetes; and what we need to further study. The Endocrine Society will continue to share the recording f the briefing along with our funding recommendations for the National Institutes of Health with congressional staff as we advocate for increased support for medical research. 

One of the Endocrine Society’s recent panels included (clockwise from top left): director of the NIDDK Griffin P. Rodgers, MD; the Endocrine Society’s chief professional and clinical affairs officer, Robert Lash, MD, ; Society member Mary Korytkowski, MD; director of the NIDDK Division of Endocrinology and Metabolism, William Cefalu, MD; and Society member Joshua Joseph, MD, MPH, FAHA.


On April 14, we hosted a “virtual” congressional briefing with the NIDDK to share recent advances and emerging opportunities with congressional staff. Congress is beginning the annual federal appropriations process of determining funding for all federal agencies, so this is an opportune time to make sure it is aware of the important research happening at all NIH Institutes.


Our briefing included a panel of NIDDK director Griffin P. Rodgers, his three division directors, and a diabetes patient to talk about the important work occurring at the NIDDK and how the Institute is addressing diversity, equity, and inclusion in the research workforce and in clinical trials.


You may also like

  • Endocrine Society Participates in European Union Activity to Advise on Implementation of its Chemical Strategy

    The Endocrine Society achieved a major victory in the new European Union (EU) Chemicals Strategy for Sustainability (CSS) by including several priority actions on endocrine-disrupting chemicals (EDCs) within the strategy. The CSS commits the EU towards a series of actions to better protect citizens and the environment and promote innovation in safe and sustainable chemicals….

  • Endocrine Society Leads Efforts to Lower Cost of Prescription Drugs

    The Endocrine Society continues to lead advocacy efforts focused on lowering the cost of diabetes medication. The Society has weighed in on recent congressional and administration activity regarding legislation and regulations aimed at lowering the price of prescription drugs.    In May, the House Energy & Commerce Health subcommittee conducted a hearing on legislation to lower the cost of prescription drugs. The Endocrine Society submitted a statement to the subcommittee calling on Congress to…

Find more in